| Year |
Title |
Altmetric |
| 2020
|
The cross-talk of NOTCH and GSK-3 signaling in colon and other cancers
2020
|
|
| 2020
|
Crafting a team-based, interprofessional undergraduate research honors curriculum in the health professions.
Journal of Allied Health.
49:E57-E62.
2020
|
|
| 2016
|
The Notch pathway in colorectal cancer.
International Journal of Cancer.
138:1835-1842.
2016
|
|
| 2015
|
Notch-1 Promotes Stemness and Epithelial to Mesenchymal Transition in Colorectal Cancer.
Journal of Cellular Biochemistry.
116:2517-2527.
2015
|
|
| 2014
|
GSK-3 as potential target for therapeutic irvention in cancer.
Oncotarget.
5:2881-2911.
2014
|
|
| 2014
|
Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: Opportunities for therapeutic intervention.
Leukemia.
28:15-33.
2014
|
|
| 2014
|
NOTCH and PTEN in prostate cancer.
Advances in Biological Regulation.
56:51-65.
2014
|
|
| 2012
|
Developmental pathways in colon cancer: Crosstalk between WNT, BMP, Hedgehog and Notch.
Cell Cycle.
11:4344-4351.
2012
|
|
| 2011
|
Label-free classification of cultured cells through diffraction imaging.
Biomedical Optics Express.
2:1717-1726.
2011
|
|
| 2009
|
Notch-1 signaling is lost in prostate adenocarcinoma and promotes PTEN gene expression.
Journal of Cellular Biochemistry.
107:992-1001.
2009
|
|
| 2009
|
Targeting the leukemic stem cell: The Holy Grail of leukemia therapy.
Leukemia.
23:25-42.
2009
|
|
| 2008
|
Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia.
Leukemia.
22:686-707.
2008
|
|
| 2008
|
HoxA9 induces insulin-like growth factor-1 receptor expression in B-lineage acute lymphoblastic leukemia.
Leukemia.
22:1161-1169.
2008
|
|
| 2008
|
Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy.
Leukemia.
22:708-722.
2008
|
|
| 2007
|
Chromosomal analysis and identification based on optical tweezers and Raman spectroscopy: Reply.
Optics Express.
15:6000-6002.
2007
|
|
| 2007
|
CBF-1 (RBP-Jκ) binds to the PTEN promoter and regulates PTEN gene expression.
Cell Cycle.
6:80-84.
2007
|
|
| 2006
|
The MLL partial tandem duplication in acute myeloid leukaemia.
British Journal of Haematology.
135:438-449.
2006
|
|
| 2006
|
Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
Advances in Biological Regulation.
46:249-279.
2006
|
|
| 2006
|
Chromosomal analysis and identification based on optical tweezers and Raman spectroscopy.
Optics Express.
14:5385-5393.
2006
|
|
| 2006
|
Synergy between an IGF-1R antibody and Raf/MEK/ERK and PI3K/Akt/mTOR pathway inhibitors in suppressing IGF-1R-mediated growth in hematopoietic cells.
Leukemia.
20:1254-1260.
2006
|
|
| 2005
|
The epidermal growth factor receptor gene family as a target for therapeutic intervention in numerous cancers: What's genetics got to do with it?.
Expert Opinion on Therapeutic Targets.
9:1009-1030.
2005
|
|
| 2005
|
Acquired immunodeficiency syndrome associated lymphoma.
Frontiers in Bioscience-Landmark.
10:2972-2977.
2005
|
|
| 2005
|
Activated EGFR promotes the survival of B-lineage acute leukemia in the absence of stromal cells.
Cell Cycle.
4:483-487.
2005
|
|
| 2005
|
Conditional EGFR promotes cell cycle progression and prevention of apoptosis in the absence of autocrine cytokines.
Cell Cycle.
4:822-830.
2005
|
|
| 2005
|
Effects of endogenous epidermal growth factor receptor signaling on DNA synthesis and ERK activation in a cytokine-dependent hematopoietic cell line.
Cell Cycle.
4:818-821.
2005
|
|
| 2005
|
Increased protein expression of the PTEN tumor suppressor in the presence of constitutively active notch-1.
Cell Cycle.
4:1389-1395.
2005
|
|
| 2005
|
Inhibition of PI3K, mTOR and MEK signaling pathways promotes rapid apoptosis in B-lineage ALL in the presence of stromal cell support.
Leukemia.
19:98-102.
2005
|
|
| 2005
|
Upping the bid on engineered inducible cell death.
Cancer Biology and Therapy.
4:537.
2005
|
|
| 2004
|
The complexity of PTEN: Mutation, marker and potential target for therapeutic intervention.
Expert Opinion on Therapeutic Targets.
8:537-550.
2004
|
|
| 2004
|
JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis.
Leukemia.
18:189-218.
2004
|
|
| 2003
|
B-cell development in the presence of the MLL/AF4 oncoprotein proceeds in the absence of HOX A7 and HOX A9 expression.
Leukemia.
17:2454-2459.
2003
|
|
| 2003
|
Treatment by design in leukemia, a meeting report, Philadelphia, Pennsylvania, December 2002.
Leukemia.
17:2358-2382.
2003
|
|
| 2002
|
Microarray analysis of a t(4;11)q(21;23) cell line with B-lineage developmental potential reveals a distinct pattern of Hox gene.
Blood.
100:195B-195B.
2002
|
|
| 2001
|
Pro-B-cell to pre-B-cell development in B-lineage acute lymphoblastic leukemia expressing the MLL/AF4 fusion protein.
Blood.
98:3398-3405.
2001
|
|
| 2001
|
VH gene replacement in thymocytes.
Journal of Immunology.
166:855-860.
2001
|
|
| 2000
|
De novo IgH gene segment rearrangement leads to functional pre-BCR expression in a novel B-lineage all cell like expressing MLL/AF4..
Blood.
96:617A-+.
2000
|
|
| 2000
|
Endogenous Notch-1 cleavage in human B-lineage cells..
Blood.
96:615A-+.
2000
|
|
| 2000
|
Microenvironmental influences on human B-cell development.
Immunological Reviews.
175:175-186.
2000
|
|
| 2000
|
Notch-1 and Notch-2 exhibit unique patterns of expression in human B-lineage cells.
Leukemia.
14:2095-2102.
2000
|
|
| 1999
|
Notch expression and signaling in normal and leukemic human B-lineage cells..
Blood.
94:436A-436A.
1999
|
|
| 1999
|
IgM heavy chain complementarity-determining region 3 diversity is constrained by genetic and somatic mechanisms until two months after birth.
Journal of Immunology.
162:6060-6070.
1999
|
|
| 1999
|
Analysis of notch during human B-lineage development.
1999
|
|
| 1999
|
The expression of long HCDR3 intervals is constrained by both genetic and somatic mechanisms during human B-cell ontogeny.
Journal of Investigative Medicine.
47.
1999
|
|
| 1998
|
V(H) gene replacement occurs in the spleen and bone marrow of non-autoimmune quasi-monoclonal mice.
European Journal of Immunology.
28:3362-3370.
1998
|
|
| 1998
|
Molecular mechanisms involved in receptor editing at the Ig heavy chain locus.
International Immunology.
10:241-246.
1998
|
|
| 1998
|
Sequence analysis of the mouse RAG locus intergenic region.
Journal of Immunology Research.
5:215-222.
1998
|
|
| 1998
|
Sequence of the Rag1 and Rag2 intergenic region in zebrafish (Danio rerio).
Journal of Immunology Research.
5:211-214.
1998
|
|
| 1997
|
Ig D(H) gene segment transcription and rearrangement before surface expression of the pan-B-cell marker CD19 in normal human bone marrow.
Blood.
90:736-744.
1997
|
|
| 1996
|
Transcriptional regulation of the recombinase activating genes in murine pre-b cells
1996
|
|
| 1996
|
The J chain gene is transcribed during B and T lymphopoiesis in humans.
Journal of Immunology.
156:4240-4244.
1996
|
|
| 1995
|
Immunoglobulin recombinase gene activity is modulated reciprocally by interleukin 7 and CD19 in B cell progenitors.
Journal of Experimental Medicine.
182:973-982.
1995
|
|
| 1995
|
ACTIVATION AND REGULATION OF HUMAN DJC-MU-GENE SEGMENT REARRANGEMENT PRIOR TO SURFACE EXPRESSION OF THE B-CELL MARKER-CD19.
Journal of Cellular Biochemistry.
112-112.
1995
|
|
| 1995
|
DJC-MU REARRANGEMENTS ARE PRESENT BUT NOT TRANSCRIBED IN HUMAN THYMOCYTES
1995
|
|
| 1995
|
J-CHAIN EXPRESSION DURING NORMAL HUMAN B-LINEAGE DEVELOPMENT
1995
|
|
| 1995
|
Analysis of DHQ52 Gene Segment Transcription and Rearrangement During B‐Cell Development in Human Fetal Bone Marrow.
Annals of the New York Academy of Sciences.
764:228-230.
1995
|
|
| 1995
|
Developmental Regulation of the Human Antibody Repertoire.
Annals of the New York Academy of Sciences.
764:242-260.
1995
|
|
| 1994
|
REGULATION OF EARLY HUMAN B-LYMPHOCYTE DIFFERENTIATION BY INTERLEUKIN-7.
Experimental Hematology.
22:717-717.
1994
|
|
| 1994
|
EARLY ACTIVATION OF THE DHQ52 PROMOTER DURING HUMAN B-CELL ONTOGENY
1994
|
|
| 1993
|
DEVELOPMENTAL REGULATION OF IMMUNOGLOBULIN DH AND JH GENE SEGMENT EXPRESSION IN MAN.
Journal of Immunology.
150:A151-A151.
1993
|
|
| 1993
|
TRANSGENIC EXPRESSION OF HUMAN TERMINAL DEOXYNUCLEOTIDYL-TRANSFERASE IN MOUSE THYMUS.
Journal of Immunology.
150:A33-A33.
1993
|
|
| 1993
|
DEVELOPMENTAL REGULATION OF DH AND JH GENE SEGMENT REARRANGEMENT IN MAN.
Journal of Cellular Biochemistry.
220-220.
1993
|
|
| 1992
|
ANALYSIS OF IMMUNOGLOBULIN DJ TRANSCRIPTS FROM BONE-MARROW AND FETAL LIVER INDICATES DEVELOPMENTAL REGULATION OF DH AND J(H) GENE SEGMENT REARRANGEMENT.
Clinical research.
40:A820-A820.
1992
|
|
